CVS Health Corporation has outperformed peers, overcoming industry headwinds through effective management and strategic execution. CVS delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low-double-digit investor returns. While Health Services and Insurance segments anticipate mid-single-digit growth, retail is set for gradual decline but with margin improvements.
Lam Research Corp (NASDAQ:LRCX) and Applied Materials Inc (NASDAQ:AMAT) are contributing to the semiconductor and memory stock rally this morning, after Goldman Sachs hiked its price targets on both names to $380 and $645, respectively.
TeraWulf stock rises sharply after the data-center operator announces a 20-year lease agreement with AI start-up Anthropic.
Nearly every core piece of the protocol will be rebuilt over three to four years, with quantum safety and privacy moved front and center.
NVIDIA's fundamentals have never looked stronger, yet its stock is limping through 2026.
Strategy's Bitcoin sale highlights the potential vulnerability of relying on volatile assets for dividend funding, impacting investor confidence. Strategy sells Bitcoin for the first time since 2022 to fund dividend payments.
Chipotle Mexican Grill is executing its 'Recipe for Growth' strategy, centered on five pillars that differentiate the brand and drive long-term expansion. Operational excellence is CMG's core competitive moat, supporting strong performance in a highly competitive fast-casual dining sector. CMG reported impressive Q1 2026 restaurant-level operating margins of 23.7%, demonstrating resilience despite inflationary pressures.
LNG, AR and GPOR offer three angles on rising natural gas demand as electricity use, grid reliability needs and LNG exports reshape U.S. energy.
Spot bitcoin ETFs recorded $5.4 billion in net outflows in the first half of 2026, marking their first negative half-year since launch. DWF Labs says the reversal reflects weaker crypto sentiment as capital and attention shift toward AI. DWF Labs Says AI Boom Coincides With Bitcoin ETFs' First $5.
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) said on Monday that it has completed dosing the final patient in its Phase 2b Elumina clinical trial evaluating investigational therapy VLS-01 for adults with treatment-resistant depression (TRD), with topline results expected in the fourth quarter of 2026. The randomized, double-blind, placebo-controlled trial enrolled 156 patients across multiple centers.
Renault Group is achieving better margins on its compact electric R5 than larger models like the Megane or Scenic, CEO Francois Provost told French business daily Les Echos on Monday.
Rotation is the theme of markets right now, says Tom White, pointing to selling in AI chip stocks while other corners of Wall Street rallied. Memory stocks remain in focus, as Tom points to movers like Micron (MU) in the U.S. and SK Hynix abroad with plans to make a domestic debut.
Gold managed to meet the target of 4200 early today. As we see from the chart, prices are facing a trading zone between support 4100 and resistance 4200-20.
USDJPY managed to pass above the short-term resistance zone of 161.95 which shows a strong advance still ongoing. Prices fell toward 160.50-70 on the suspected intervention before bouncing back.
GBPUSD rebounded further after testing the support at 1.3160 as the market closed from the 1.3400-30 resistance zone. If prices remain below this zone, another retreat toward 1.3305 and 1.3160 could hit the market.
The Euro advanced after the US payroll last Friday. Intraday shows the same levels with support at 1.1380 could keep the chance for a move to test the 1.1500-25 resistance zone.
What's the difference between a stock that is oversold and one that is undervalued?
I initiate MBX Biosciences with a speculative buy, anchored by Canvuparatide's de-risked clinical profile and differentiated dosing convenience. MBXX's Precision Endocrine Peptide platform enables longer-acting, less frequent dosing, addressing key safety and compliance issues in hypoparathyroidism and obesity. Canvuparatide's Phase 2 data show strong efficacy and patient benefit, but Phase 3 must address PK variability and long-term calcium control risks.
Mastercard underperformed the benchmark, remaining flat over the past 7 months while the benchmark gained 9%. Despite recent underperformance, MA's long-term investment thesis has improved due to several emerging tailwinds. My previous neutral stance was justified, but evolving factors now support a more constructive outlook on MA.
Solstice Advanced Materials has struck a deal to buy specialty chemicals maker Element Solutions for more than $12 billion in cash and stock.
Solana's user surge highlights its growing influence and potential to boost market confidence, impacting blockchain competition dynamics. Solana active users surge 77% to 29.7M in two weeks.
Cardano (ADA) slipped 4% on July 6, trading around $0.18 and emerging as the weakest performer among the top 10 cryptocurrencies by market capitalization. The decline comes as long liquidations and falling open interest increase selling pressure, even as Cardano founder Charles Hoskinson remains optimistic about the networks long-term outlook.
The sterling pound has seen a notable recovery in recent weeks, following a sharp decline in late June. The GBP/USD pair has experienced a seven-session winning streak, moving from a seven-month low near $1.3200 to the $1.3350-$1.3380 range.
Bitcoin touched $64,000 for the first time in roughly two weeks but quickly lost more than $1,000 and moved back below $63,000. June delivered a 20% decline, Bitcoin's worst month in exactly four years, before July's dip under $58,000 and subsequent rebound.
Rocket Lab stock has remained volatile in the wake of the highly anticipated SpaceX IPO and its blockbuster Iridium acquisition. Shares surged to $151 ahead of the IPO before tumbling to $80.50, and have since recovered to around $100.
Rogers Communications is buying out the final portion of the Maple Leaf Sports and Entertainment from Larry Tanenbaum's Kilmer Sports for 4.35 billion Canadian dollars.
XRP is showing renewed strength after weeks of volatile trading, with market participants increasingly optimistic that the cryptocurrency could extend its gains before the end of July. Despite consolidating around the $1.13-$1.14 range, traders on prediction platform Kalshi believe XRP still has room to climb, with 33% forecasting the token could reach $1.30 by month-end.
The Bitcoin treasury giant sold $216 million worth of Bitcoin to cover preferred payouts, as an $8.3 billion quarterly loss piled up.
Data center provider Csquare is targeting a valuation of up to $4.18 billion in its U.S. initial public offering, riding a wave of investor enthusiasm for companies expected to benefit from the AI boom.